Skip to content

Estimate blood loss in intravenous vitamin c versus placebo in patient with total abdominal hysterectomy: Randomized Controlled Trial, single center

Estimate blood loss in intravenous vitamin c versus placebo in patient with total abdominal hysterectomy: Randomized Controlled Trial, single center

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260114006
Enrollment
40
Registered
2026-01-14
Start date
2024-09-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To compare estimated blood loss between patients who underwent total abdominal hysterectomy with or without salpingo-oophorectomy in patients who received Vitamin C and placebo Vitamin C

Interventions

intravenous vitamin C 1 g preoperatively and 1 g intraoperatively,Normal saline intravenous 100ml preoperatively and 100ml intraoperatively
Experimental Drug,Placebo Comparator No treatment
Vitamin C,Normal saline

Sponsors

Queen Savang Vadhana Memorial Hospital, Thailand
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Female patients who underwent total abdominal hysterectomy, with or without bilateral salpingo-oophorectomy. 2. No bleeding tendency. 3. No history of anticoagulant or thrombolytic drug use within 7 days prior to surgery. 4. No contraindications to vitamin C supplementation (e.g., patients with G6PD deficiency, renal disease, or hepatic disease). 5. No history of allergy to vitamin C.

Exclusion criteria

Exclusion criteria: 1. Inability to communicate in the Thai language. 2. Underwent total abdominal hysterectomy due to gynecologic malignancy. 3. Required emergency total abdominal hysterectomy. 4. History of vitamin C supplementation within 2 weeks prior to surgery. 5. History of smoking. 6. Previous abdominal surgery, such as bowel surgery, cesarean section, appendectomy, oophorectomy, myomectomy, or salpingectomy (e.g., due to ectopic pregnancy or tubal ligation).

Design outcomes

Primary

MeasureTime frame
Estimated blood loss after operation Suction and weighing gauze

Secondary

MeasureTime frame
Changes in hemoglobin (Hb) and hematocrit (Hct) 1 day before and after operation Complete blood count,Length of hospital stay discharged day

Countries

Thailand

Contacts

Public ContactAektanat Tawornkitpanich

Queen Savang Vadhana Memorial Hospital, Thailand

tiesuke@gmail.com038320200

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026